StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.21+0.14 (+0.56%)

Close on Nov 17, 2026Market cap $666.15MP/E –Yield –

Fulgent Genetics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Fulgent Genetics's total debt was $1.48M at Jun 30, 2026. For fiscal 2025 it was $1.96M, down 21.5% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.96M-21.5%
FY2024Dec 31, 2024$2.49M-15.9%
FY2023Dec 31, 2023$2.96M-12.1%
FY2022Dec 31, 2022$3.37M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.48M-24.6%
Q1 FY2026Mar 31, 2026$1.48M-24.6%
Q4 FY2025Dec 31, 2025$1.96M-21.5%
Q3 FY2025Sep 30, 2025$1.96M-21.5%
Q2 FY2025Jun 30, 2025$1.96M-21.5%
Q1 FY2025Mar 31, 2025$1.96M-21.5%
Q4 FY2024Dec 31, 2024$2.49M-15.9%
Q3 FY2024Sep 30, 2024$2.49M-26.1%
Q2 FY2024Jun 30, 2024$2.49M-58.1%
Q1 FY2024Mar 31, 2024$2.49M-57.7%
Q4 FY2023Dec 31, 2023$2.96M–
Q4 FY2022Dec 31, 2022$3.37M–
Q3 FY2021Sep 30, 2021$5.95M–
Q2 FY2021Jun 30, 2021$5.90M–

More Fulgent Genetics figures

See a number that looks wrong?